Jasbir Seehra - 19 Feb 2026 Form 4 Insider Report for Keros Therapeutics, Inc. (KROS)

Signature
/s/ Keith Regnante, Attorney-in-Fact
Issuer symbol
KROS
Transactions as of
19 Feb 2026
Net transactions value
-$113,433
Form type
4
Filing time
20 Feb 2026, 16:15:17 UTC
Previous filing
09 Jan 2026
Next filing
26 Feb 2026

Sponsored

Quoteable Key Fact

"Jasbir Seehra filed Form 4 for Keros Therapeutics, Inc. (KROS) on 20 Feb 2026."

Quick Takeaways

  • This page summarizes Jasbir Seehra's Form 4 filing for Keros Therapeutics, Inc. (KROS).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Filing timestamp: 20 Feb 2026, 16:15.

What Changed

  • Previous filing in this sequence was filed on 09 Jan 2026.
  • Current net transaction value: -$113,433.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Seehra Jasbir CHIEF EXECUTIVE OFFICER, Director C/O KEROS THERAPEUTICS, INC., 1050 WALTHAM STREET, SUITE 302, LEXINGTON /s/ Keith Regnante, Attorney-in-Fact 20 Feb 2026 0001732369

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KROS Common Stock Sale $113,433 -7,015 -1.8% $16.17 385,708 19 Feb 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.